view5G Networks Ltd

5G Networks executes CBA facility, completes APTel acquisition

The funding enables 5G to complete the acquisition while maintaining strong cash reserves.

5G aims to unify a seamless digital experience across data connectivity, cloud and managed services in the business-to-business market

5G Networks Ltd (ASX:5GN) has executed its debt facility with the Commonwealth Bank of Australia (CBA).

The agreement with CBA to provide the $5.5 million loan was for the purpose of completing 5G’s Asia Pacific Telecommunications (APTel) acquisition, consolidating lease obligations and to bolster working capital.

With funds on hand, the telecom company is well positioned to deliver on its growth plans and enhance the positive operating cashflows currently being generated.

READ: 5G Networks acquires one of Australia’s largest cloud providers

5G managing director Joe Demase said: “As we announced in October the debt facility has given us the flexibility to both complete this successful acquisition and to enhance our cash position while we strengthen cash flow.

“Both the APTel and Inabox Direct acquisitions have combined to drive our annualised revenue to notable levels circa $55 million.

“This allows 5G Networks to be in a very strong position as we aggressively pursue cloud, digital and data networking opportunities that enhance our current business, both organically and through strategic acquisitions.”

The acquisition of APTel from the Deague Group is now complete with the final $3 million of the $6-million acquisition paid.

APTel has added more than 800 customers to 5G Networks’ customer base representing annualised revenue of $6.4 million.

Quick facts: 5G Networks Ltd


Price: 0.905 AUD

Market Cap: $109.2 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Destiny Pharma's hail 'win win deal' as China partner begins programme with...

Destiny Pharma PLC (AIM:DEST) (AIM:DEST) Neil Clark talks to Proactive London about their partner in China, Hong Kong listed China Medical System Holdings (HKG:0867) (HKG:0867) Ltd (CMS) launching a new programme aimed at delivering a new product using Destiny’s XF-73.  Their aim differs to...

5 hours, 16 minutes ago

2 min read